Suckfuell, Markus <br/><br/>
Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study.  [electronic resource] 

 -  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology  Sep 2014 
 - 1317-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-4505 
<br/><br/><label>Standard No.: </label>10.1097/MAO.0000000000000466  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Hearing Loss, Sensorineural--drug therapy<br/>Hearing Loss, Sudden--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuroprotective Agents--administration & dosage<br/>Peptides--administration & dosage<br/>Prospective Studies<br/>Tinnitus--drug therapy<br/>Treatment Outcome<br/>Tympanic Membrane--drug effects<br/>Young Adult